LBX Pharmacy Chain JSC
SSE:603883
LBX Pharmacy Chain JSC
SSE:603883
Price:
32.58 CNY
-1.45%
Market Closed
Updated:
Jun 10, 2024
LBX Pharmacy Chain JSC
Total Liabilities & Equity
|
LBX Pharmacy Chain JSC
Total Liabilities & Equity Peer Comparison
Comparables:
D
603233
605266
603939
301017
002727
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LBX Pharmacy Chain JSC
SSE:603883
|
Total Liabilities & Equity
¥21.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Total Liabilities & Equity
¥24.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Total Liabilities & Equity
¥9.9B
|
CAGR 3-Years
42%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Total Liabilities & Equity
¥24.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Total Liabilities & Equity
¥9.3B
|
CAGR 3-Years
45%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Total Liabilities & Equity
¥16.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
See Also
What is LBX Pharmacy Chain JSC's Total Liabilities & Equity?
Total Liabilities & Equity
21.2B
CNY
21.2B
CNY
Based on the financial report for Mar 31, 2024, LBX Pharmacy Chain JSC's Total Liabilities & Equity amounts to 21.2B CNY.
What is LBX Pharmacy Chain JSC's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
19%
19%
Over the last year, the Total Liabilities & Equity growth was 0%. The average annual Total Liabilities & Equity growth rates for LBX Pharmacy Chain JSC have been 15% over the past three years , 19% over the past five years .
You don't have any saved screeners yet
